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The restriction factor SAMHD1 limitsHIV-1 replication
in noncycling cells. SIV and HIV-2 overcome this re-
striction via the accessory protein Vpx, which targets
SAMHD1 for degradation through interactions with
the host ubiquitin ligase adaptor DCAF1. However,
the factors used by HIV-1 to replicate in macro-
phages, despite the presence of the restriction factor
SAMHD1, are unknown. Using a yeast two-hybrid
screen,we identifiedcyclin L2as aDCAF1-interacting
protein required forHIV-1 replication inmacrophages.
Knockdown of cyclin L2 results in severe attenuation
of HIV-1 replication in macrophages but not cycling
cells, and this effect is lost in the absenceof SAMHD1.
Cyclin L2 and SAMHD1 form a molecular complex
that is partially dependent on the presence of
DCAF1 and results in SAMHD1 degradation in a pro-
teasome- and DCAF1-dependent manner. Therefore,
cyclin L2-mediated control of SAMHD1 levels in mac-
rophages supports HIV-1 replication.
INTRODUCTION
HIV-2 and its counterpart, simian immunodeficiency virus (SIV),
encode the accessory protein Vpx, which facilitates the efficient
infection of quiescent noncycling cells like macrophages, resting
T cells, and dendritic cells (Ueno et al., 2003; Srivastava et al.,
2008). Vpx also endows HIV-1 with the ability to replicate effi-
ciently in nondividing cells when it is supplied in trans or pack-
aged into incoming virions, suggesting that Vpx disables a
restriction factor in the very early steps of viral replication.
Recently, SAMHD1was identified as the critical restriction factor
targeted by Vpx. Degradation of SAMHD1 by Vpx in macro-
phages, dendritic cells, and resting T cells allows for efficient
infection by HIV-2/SIV (Laguette et al., 2011; Hrecka et al.,
2011; Baldauf et al., 2012). In addition, depletion of SAMHD1
from nondividing cells, either by Vpx or by genetic knockdown,
leads to more effective HIV-1 replication. Furthermore, Vpx
binds to SAMHD1, and promotes its degradation in the protea-
some (Brandariz-Nun˜ez et al., 2012; Ahn et al., 2012). The degra-
dation process requires Vpx to also bind to DCAF1, the Cul4A
ubiquitin ligase adaptor (Wei et al., 2012; Zhu et al., 2013).98 Cell Host & Microbe 17, 98–106, January 14, 2015 ª2015 ElsevierDespite the critical role of SAMHD1 as a restriction factor in
nondividing cells, little is known about how it is regulated.
SAMHD1 has been shown earlier as one of the genes mutated
in children with Aicardi–Goutie`res syndrome (Rice et al., 2009;
Dale et al., 2010). In this rare genetic disorder, children present
with symptoms resembling those of an overwhelming viral infec-
tion, the result of an excessive type I interferon response to circu-
lating nucleic acids. SAMHD1 has an N-terminal sterile a motif
(SAM) domain and a C-terminal histidine aspartic acid (HD)
domain. The HD domain acts as a deoxyguanosine triphos-
phate-dependent triphosphohydrolase (St Gelais et al., 2012;
Goldstone et al., 2011; Zhu et al., 2013). Several groups found
that depletion of deoxynucleotide triphosphates (dNTPs) by
SAMHD1 reduces the nucleotide pools in nondividing cells and
prevents efficient HIV replication. Limited levels of dNTPs in
nondividing cellsmay explain why SAMHD1 restricts HIV replica-
tion in macrophages, dendritic cells, and resting T cells but not in
actively dividing T lymphocytes. In addition, the antiviral activity
of SAMHD1 in noncycling compared with cycling cells may be
explained by posttranslational modification. SAMHD1 is phos-
phorylated by cyclin A2/Cdk1 in dividing but not in nondividing
cells. Phosphorylated SAMHD1 is unable to restrict HIV but re-
tains deoxynucleotide triphosphate triphosphohydrolase activity
(Cribier et al., 2013; White et al., 2013). Although differentiated
macrophages express large amounts of SAMHD1, HIV-1 is
able to replicate in these cells. Therefore, the restriction imposed
by SAMHD1 on HIV-1 in macrophages is incomplete, suggesting
that HIV-1 has a mechanism to overcome SAMHD1 or that HIV-1
utilizes a cellular factor that regulates SAMHD1 activity.
Because Vpx requires interaction with DCAF1 for efficient
macrophage infection by SIV/HIV-2, we postulated that other
DCAF1-interacting proteins may play a role in HIV infection of
macrophages. Therefore, we performed a yeast two-hybrid
screen using a T cell library from Clontech Laboratories and
identified cyclin L2 as a DCAF1-interacting protein. Cyclin L2 is
part of the recently discovered family of cyclin L proteins, con-
sisting of cyclin L1 and cyclin L2. It possesses an N-terminal cy-
clin box and a C-terminal serine arginine (SR) domain, and it has
been shown to be involved in cell cycle regulation and pre-mRNA
splicing (Yang et al., 2004; de Graaf et al., 2004; Li et al., 2007;
Loyer et al., 2008; Zhuo et al., 2009).
In this study, we show that depletion of cyclin L2 attenuates
HIV replication in macrophages but not in dividing cells. We
found that cyclin L2 interacts with and targets SAMHD1 for
degradation in a proteasome- and DCAF1-dependent manner.
Moreover, we found that, during the early phase of HIV infectionInc.
Figure 1. Screening of Putative DCAF1-Interacting Proteins for Their Effect on HIV Replication Identifies Cyclin L2
(A) Western blot (WB) showing shRNA knockdown of the indicated genes in PMA-differentiated THP-1 cells.
(B–D) THP-1 cells stably expressing the indicated or control shRNA were differentiated with 50 ng/ml of PMA for 48 hr and infected with HIV-1Luc, HIV-2Luc, or
HIV-2DVpxLuc. After 2 days, cells were lysed for luciferase luminescence. Luciferase luminescence for four triplicate experiments were pooled and expressed as
fold change of the control shRNA. Data indicate means. Error bars indicate ± SEM (nR 3). **p < 0.01 (ANOVA).
See also Figure S1.in macrophages, the level of cyclin L2 is negatively correlated
with that of SAMHD1. We present several lines of evidence to
show that cyclin L2 is an important endogenous regulator of
SAMHD1 and a critical HIV dependency factor in macrophages.
RESULTS
A Screen of Putative DCAF1-Interacting Proteins
Identifies Cyclin L2 as an HIV Dependency Factor
The HIV accessory proteins Vpr and Vpx are important for HIV
replication in macrophages. Both proteins require interaction
with the Cul4A ubiquitin ligase adaptor DCAF1 for their ability
to induce cell cycle arrest in the case of Vpr and degradation
of the restriction factor SAMHD1 by Vpx (Fregoso et al., 2013;
Romani and Cohen, 2012; Wei et al., 2012; Srivastava et al.,
2008). We postulated that other DCAF1-interacting proteins
may play a role in HIV replication, especially in quiescent cells
like macrophages where the effects of Vpx and Vpr on virus
replication are most prominent. To test this idea, we performed
a screen for DCAF1-interacting proteins using the yeast two-
hybrid method, employing full-length and truncated DCAF1 pro-
teins as baits. Based on the proteins identified in the screen and
those identified recently as putative DCAF1-interacting proteins
(Hrecka et al., 2011; Laguette et al., 2011), we selected five
gene products to test their ability to restrict or potentiate HIV
replication in macrophages. For this purpose, we generated sta-
ble THP-1 monocytoid cell lines selected in puromycin using a
cocktail of small hairpin RNASs (shRNAs) for each gene ex-
pressed in the lentiviral vector, pLKO.puro. Significant depletion
of each of these gene products was obtained (Figure 1A). After
differentiation in PMA for 48 hr, cells were infected with vesicu-
lar stomatitis virus glycoprotein (VSV-G)-pseudotyped HIV-
1Luc, HIV-2Luc, or HIV-2DVpxLuc reporter viruses for 48 hr.
We expected that, compared with controls, restriction factors
will show increased HIV replication upon mRNA knockdown,
whereas dependency factors will show reduced HIV replication,
as measured by intracellular luciferase luminescence readouts
in infected cells. The assay was validated using knockdown
of the restriction factor SAMHD1 as a positive control. There
was a 4-fold increase in HIV-1 replication with SAMHD1 deple-Cell Hotion, as expected (Figures S1A and S1B available online). Out of
the five genes screened, knockdown of CCNL2, which encodes
cyclin L2, resulted in a significant reduction in the replication of
HIV-1 (5-fold), HIV-2 (2.7-fold), and HIV-2DVpx (4-fold) (Figures
1B–1D), indicating that it could be a potential HIV dependency
factor.
Cyclin L2 Is a DCAF1-Interacting Protein
Because cyclin L2 was identified as a DCAF1-interacting protein
in yeast, we confirmed that it is expressed and interacts with
DCAF1 in mammalian cells. Figure 2A shows that cyclin L2 is
expressed ubiquitously in various cell types relevant to HIV
biology, includingmonocyte-derivedmacrophages, THP-1 cells,
and T cell lines. To confirm that cyclin L2 interacts with DCAF1 in
mammalian cells, immunofluorescence and immunoprecipita-
tion experiments were performed. Expression of cyclin L2 in
HeLa cells showed that it is localized in the nucleus and partially
colocalized with DCAF1 (Figure 2B; Figure S2A). Cells trans-
fected with cyclin L2 showed intranuclear vacuoles, as
described previously (Yang et al., 2004). Moreover, with a pull-
down of either protein, cyclin L2 and DCAF1 were together in
immunoprecipitates, indicating that the two proteins are closely
associated (Figures 2C and 2D). More importantly, we could
detect interaction between cyclin L2 and DCAF1 when immuno-
precipitations were performed in untransfected THP-1 cells
(Figure 2E; Figure S2B). Moreover, DDB1 and Cul4a, other com-
ponents of the ubiquitin ligase complex, were also detected in
the immunoprecipitates. Taken together, these data show that
cyclin L2 is an HIV dependency factor that interacts with DCAF1.
Depletion of Cyclin L2 Inhibits HIV Replication in
Nondividing Cells
To further define the effect of cyclin L2 on HIV replication, we
made different individual shRNAs targeting the CCNL2 mRNA
in THP-1 cells. Knockdown of cyclin L2 was achieved with
several of the shRNAs in THP-1 cells differentiated with PMA
for 48 hr (Figure 3A).
Differentiated THP-1 cells were infected with the HIV-
2DVpxLuc reporter virus. In each of the shRNA knockdowns,
we detected a significant reduction in HIV-2DVpx replication,st & Microbe 17, 98–106, January 14, 2015 ª2015 Elsevier Inc. 99
Figure 2. Cyclin L2 Is Ubiquitously Expressed and Interacts with DCAF1 in Mammalian Cells
(A) WB showing expression levels of cyclin L2 in various cell lines and MDMs. *Differentiated THP-1.
(B) Cyclin L2 and DCAF1 show partial colocalization in the nucleus. HeLa cells were transfected with myc-cyclin L2 and stained for myc and endogenous DCAF1.
See also Figure S2.
(C and D) 293T cells were transfected with cyclin L2 and DCAF1 for 48 hr, and then cells were lysed and immunoprecipitation (IP) was performed using polyclonal
DCAF1, cyclin L2 antibody, or an immunoglobulin G (IgG) control (CTR). Western blots were probed with DCAF1 or cyclin L2 antibodies.
(E) Differentiated THP-1 cells were lysed, and immunoprecipitation performed with DCAF1 antibody and blotted for the indicated proteins. The blots shown
represent one of two or three independent experiments.as measured by luciferase activity (Figure 3B). The shRNA
with the greatest effect on HIV-2DVpx replication, designated
shRNA2, was used to examine the effect of cyclin L2 knockdown
on HIV-1 in subsequent experiments. We found a profound
decrease in HIV-1 replication in THP-1 cells when cyclin L2
was depleted (Figure 3C). The decrease in HIV-1 replication
was not due to reduced proliferation or enhanced apoptosis of
cells transduced with cyclin L2 shRNA, as evidenced by similar
levels of (3-(4,5-dimethylthiazolyl-2)-2,5-diphenyltetrazolium
bromide (MTT) incorporation in control and cyclin L2-depleted
cells (Figure 3D). In addition, HIV entry was not affected by cyclin
L2, as shown by an intracellular p24 ELISA assay at 2 hr postin-
fection (Figure S1C). We then tested the effect of cyclin L2 in hu-
manmonocyte-derived macrophages from two different donors.
Human monocyte-derived macrophages were transduced with
control or cyclin L2 shRNA and infected with HIV-1Luc, and lucif-
erase readouts were measured on cell lysates. In both donors,
there was a more than 6-fold reduction in HIV-1 replication
upon knockdown of cyclin L2 (Figures 3E–3G). To confirm that
the effect seen in luciferase activity translated into HIV-1 gene
products, we examined intracellular Gag production. Compared
with controls, there was a significant decrease in HIV-1 Gag
protein with cyclin L2 depletion (Figures 3H–3J). However, we
did not detect a change in HIV-1 replication when cyclin L2
was depleted or overexpressed in human embryonic kidney
293T (HEK293T) cells (Figures S3A–S3D) or depleted in HeLa
cells (Figures S3E and S3F), suggesting that the effect of cyclin
L2 is restricted to nondividing cells. Taken together, these data
confirm cyclin L2 as a significant HIV dependency factor in
macrophages.100 Cell Host & Microbe 17, 98–106, January 14, 2015 ª2015 ElsevieCyclin L2 Interacts with SAMHD1
We found cyclin L2 to be critical for HIV replication, but the effect
was restricted to differentiated THP-1 cells and monocyte-
derived macrophages, cell types that are terminally differenti-
ated and not actively dividing. The cell types in which cyclin L2
is active for HIV replication are similar to those in which SAMHD1
acts as a restriction factor. In addition, cyclin L2 interacts with
DCAF1, which is also required for SAMHD1 degradation through
Vpx in the context of HIV-2 infection. Therefore, we wondered
whether cyclin L2 and SAMHD1 interact with each other. Upon
expression of SAMHD1 in HeLa cells, we found significant
nuclear colocalization with cyclin L2 (Figure 4A; Figure S4). We
also performed protein interaction studies using HEK293T cells
and found that SAMHD1 and cyclin L2 coimmunoprecipitated
(Figures 4B and 4C). The coimmunoprecipitation between cyclin
L2 and SAMHD1 was present but reduced in DCAF1-depleted
cells (Figure 4D), indicating that the interaction between cyclin
L2 and SAMHD1 depends at least partially on DCAF1. More-
over, we found interaction between endogenous cyclin L2 and
SAMHD1 in differentiated THP-1 cells (Figure 4E), attesting to
the physiological significance of these interactions.
Cyclin L2 Degrades SAMHD1 through the Proteasome
Because cyclin L2 and SAMHD1 exhibited colocalization and
coimmunoprecipitation, we sought to determine whether there
was a functional relationship between these two proteins. One
possibility that could explain the sensitivity of HIV-1 and HIV-2
to cyclin L2 depletion is that cyclin L2 depletion leads to
increased SAMHD1 levels. This would suggest that cyclin L2 is
a natural regulator for SAMHD1 in terminally differentiated cells.r Inc.
Figure 3. Cyclin L2 Is Required for HIV Replication in Macrophages
(A and B) Stable THP-1 cell lines expressing different shRNAs to cyclin L2 or control shRNA were differentiated for 48 hr in PMA and infected with HIV-2DVpxLuc
for 48 hr. (A) The western blot shows knockdown of cyclin L2 prior to infection. (B) Viral replication is shown as luciferase units in infected cell lysates.
(C) Differentiated THP-1 cells expressing shRNA2 from (A) or control cells were infectedwith HIV-1Luc for 48 hr, and luciferase luminescencewasmeasured in cell
lysates.
(D) Differentiated THP-1 cells expressing the indicated shRNAs were infected with HIV-1Luc for 48 hr, washed, and used for a proliferation (MTT) assay.
(E–G) Human peripheral blood MDMs expressing control or cyclin L2 shRNAs were infected with HIV-1Luc for 48 hr, and HIV replication was measured as
luciferase units in infected cells. (E) shows a western blot of cyclin L2 knockdown from two different donors. Three parallel experiments were performed for each
donor using the different shRNA preparations. HIV replication in control versus cyclin L2 shRNA expressing cells (F and G).
(H) Differentiated THP-1 cells expressing control or cyclin L2 shRNA were infected with HIV-1 for 72 hr and immunoblotted for cyclin L2, HIV-1 Gag, and actin.
(I) Quantification (ratio of Gag to Actin band intensities).
(J) MDMs infected with HIV-1 from donor 2 were immunoblotted for HIV-1 Gag and Actin. Longer exposure times were required for p55 and p41. Data indicate
means, and error bars indicate ± SEM (nR 3). **p < 0.001, *p < 0.05, p > 0.05 (ANOVA for multiple comparisons and Student’s t test for pairwise comparisons).
See also Figures S1 and S3.To test this idea, we cotransfected SAMHD1 and cyclin L2 in
HEK293T cells using increasing concentrations of a cyclin L2
expression plasmid. We found that SAMHD1 was degraded by
cyclin L2 overexpression in a dose-dependent manner (Fig-
ure 5A). This degradation was partially rescued upon addition
of the proteasome inhibitor MG132 (Figure 5B). In addition,
SAMHD1 degradation was potentiated when protein synthesis
was blocked with cycloheximide (Figure 5C). Because Vpx
degradation of SAMHD1 is dependent on DCAF1 and because
cyclin L2 also interacts with DCAF1, we tested whether cyclin
L2-dependent degradation of SAMHD1 was DCAF1-dependent.
As shown in Figure 5D, degradation of SAMHD1 by cyclin L2was
abolished in cell lines where DCAF1 was depleted (Figures 5D
and 5E). In addition, knockdown of DNA binding protein 1
(DDB1) abrogated the effect of cyclin L2 overexpression on
SAMHD1 (Figures 5F and 5G), showing that cyclin L2-mediatedCell Hosdegradation of SAMHD1 requires an intact DCAF1-DDB1 com-
plex. When we overexpressed SAMHD1 in increasing amounts,
cyclin L2 was not degraded (Figure S5A), suggesting that
SAMHD1 is brought to the DCAF1 complex by cyclin L2 and
not vice versa. In knockdown experiments in differentiated
THP-1 cells, depletion of cyclin L2 led to increased levels of
SAMHD1 (Figures 5H and 5I). Taken together, these findings
show a role for cyclin L2 in controlling the abundance of
SAMHD1, which could explain the effect of cyclin L2 onHIV repli-
cation in macrophages. Given recent evidence that SAMHD1 is
phosphorylated by cyclin A/Cdk1 (Cribier et al., 2013; White
et al., 2013), we determined whether cyclin L2 depletion has an
effect on SAMHD1 phosphorylation. As shown in Figure S5B,
depletion of cyclin L2 increased the overall levels of SAMHD1
but did not have an effect on SAMHD1 phosphorylation, as
examined by Phos-Tag SDS-PAGE.t & Microbe 17, 98–106, January 14, 2015 ª2015 Elsevier Inc. 101
Figure 4. Cyclin L2 Interacts with SAMHD1
(A) HeLa cells were transfected with SAMHD1 overnight and immunostained for SAMHD1 and endogenous cyclin L2. See also Figure S4.
(B) HEK293T cells were transfected with control, SAMHD1, or both cyclin L2 and SAMHD1 expression plasmids. After 48 hr, cyclin L2 was immunoprecipitated
using myc monoclonal antibody. Western blots were probed with cyclin L2 and SAMHD1 antibodies.
(C) HEK293T cells were transfected with cyclin L2 and SAMHD1, and immunoprecipitation was performed using SAMHD1 or isotype IgG control antibody.
(D) 293T cells stably expressing control or DCAF1 shRNA were transfected with cyclin L2 and SAMHD1 plasmid, and immunoprecipitation was performed with
SAMHD1 or IgG antibody.
(E) Differentiated THP-1 cells were lysed, and immunoprecipitation was performed with SAMHD1 antibody or an isotype IgG control. The blots shown represent
one of two or three independent experiments.The Effect of Cyclin L2 Depletion on HIV-1 Replication Is
Aborted upon SAMHD1 Knockdown
Given that SAMHD1 depletes triphosphate nucleotide levels,
which restricts HIV reverse transcription (RT), we determined
whether depletion of cyclin L2 results in lower levels of HIV-1
RT products. We found a 3-fold reduction of HIV-1 late RT prod-
ucts upon cyclin L2 depletion in differentiated THP-1 cells (Fig-
ure 6A), showing that depletion of cyclin L2 results in increased
SAMHD1 and less HIV-1 replication. For direct evidence that
HIV-1 replication in cyclin L2-depleted cells is dependent on
SAMHD1 levels, we made stable THP-1 cells with knockdown
of both genes. Our reasoning was that if depletion of cyclin L2
promotes SAMHD1 action, then double knockdown will restore
HIV-1 replication. When the cells were infected with HIV-1,
SAMHD1 knockdown restored HIV-1 replication close to control
levels in cyclin L2-depleted cells (Figure 6B). This was also seen
with measurement of HIV-1 p55 in immunoblots (Figures 6C and
6D), showing that cyclin L2 controls SAMHD1 levels in vivo and
that the effect is borne out in HIV replication. In addition, it shows
that HIV-1 replication in macrophages is dependent on the pres-
ence of cyclin L2whenSAMHD1 is depleted bymeans other than
through cyclin L2. It is noteworthy that, whenmeasured by HIV-1
p55 Gag, the upregulation of HIV-1 upon SAMHD1 depletion is
not as robust compared with luciferase measurements.
Because several lines of evidence indicated that cyclin L2 con-
trols SAMHD1 levels to enable efficient HIV infection in macro-
phages, wewonderedwhether there was a temporal relationship
between the two proteins during HIV infection. To test this idea,
we performed time course immunoblotting for levels of cyclin L2
and SAMHD1 upon HIV-1 infection of differentiated THP-1 cells.102 Cell Host & Microbe 17, 98–106, January 14, 2015 ª2015 ElseviePrior to infection, cyclin L2 and SAMHD1 are in equilibrium in
THP-1 cells (Figure 6E). Upon HIV-1 infection, we detected an
initial downregulation of cyclin L2 levels, followed by increased
levels at 6 hr postinfection, which correlated with decreased
SAMHD1 levels. When the same experiment was repeated in
cyclin L2-depleted cells, SAMHD1 levels remained constant.
These data further strengthen our hypothesis that cyclin L2 con-
trols SAMHD1 levels in macrophages to permit HIV infection.
DISCUSSION
In this study, we identified cyclin L2 as a critical HIV dependency
factor in macrophages, the levels of which are negatively corre-
lated with SAMHD1 upon HIV infection. Knockdown of cyclin L2
in macrophages decreased HIV replication several-fold in differ-
entiated THP-1 cell lines and primary macrophages. Cyclin L2
interacts with SAMHD1, resulting in proteasomal degradation
of SAMHD1. In cells in which SAMHD1 is depleted, the effect
of cyclin L2 knockdown on HIV is abrogated. Therefore, the
effect of cyclin L2 on HIV replication is, at least in part, through
its regulation of SAMHD1 levels.
Cyclin L2 is the dominant member of the cyclin L group of cy-
clins, consisting of several isoforms of cyclin L1 and cyclin L2
(Herrmann et al., 2007; Yang et al., 2004; de Graaf et al., 2004).
Unlike SAMHD1, which is not expressed in T cell lines or U937
cells (Hrecka et al., 2011), cyclin L2 was expressed in all cell
types examined and has been found to be expressed in several
tissues (Loyer et al., 2008). In dividing cells, cyclin L2 is important
for pre-mRNA splicing through association with splicing factors
(Herrmannetal., 2007;Yangetal., 2004). This suggests that cyclinr Inc.
Figure 5. Cyclin L2 Degrades SAMHD1 through the Proteasome
(A) 293T cells were transfected with increasing concentrations of cyclin L2 and 1 mg of SAMHD1 for 48 hr, and the expression levels of the two proteins were
determined by western blot.
(B) Cotransfection of cyclin L2 and SAMHD1 in HEK293T cells with 10 mM of MG132 added after 24 hr. WB was performed after an additional 16 hr.
(C) 293T cells were transfected with cyclin L2 and SAMHD1. After 48 hr, protein synthesis was blocked with 10 mM of cycloheximide (CHX) for 6 hr, and WB was
performed on cell lysates.
(D) Stable HEK293T cells expressing control or DCAF1 shRNA were transfected with cyclin L2 and SAMHD1, and WB was performed after 48 hr.
(E) Quantification of SAMHD1/Actin band intensities from the experiments in (D).
(F) Stable HEK293T cells expressing control or DDB1 shRNA were transfected with cyclin L2 and SAMHD1, and WB was performed after 48 hr.
(G) Quantification of SAMHD1/Actin band intensities from the experiments in (F).
(H and I) THP-1 cells were transfected with cyclin L2 siRNA or transduced with shRNA, differentiated for 48 hr and then WB was performed for their expression
levels.
Data indicate means, and error bars indicate ± SEM (nR 3). *p < 0.05. See also Figure S5.L2 may be an essential protein in dividing cells. In line with this
idea, whenever we selected dividing cells in puromycin with
shRNA to cyclin L2, we could not achieve knockdown (data not
shown).When selected THP-1cellswere differentiated, however,
knockdown was readily achieved. In terminally differentiated
cells, cyclins may play a role other than cell cycle regulation.
Several cyclins have been implicated in HIV replication, notably
cyclin T1 and, most recently, cyclin A/B (Cribier et al., 2013; Wel-
bourn et al., 2013).Herecyclin L2 is added to that growing list.Our
findings show that cyclins can be coopted to participate in effi-
cient replication of HIV, enabling replication to occur in macro-
phages even in the presence of potent restriction factors like
SAMHD1. Consistent with this assertion, levels of cyclin T1
have been shown to be induced during the early phase of HIV-1
infection inmonocytes/macrophages,with levels dropping signif-
icantly after about a week of infection through proteasome-medi-
ated proteolysis. The levels of cyclin T1 can increase again in
response to pathogen-associated molecular patterns (PAMPs)
raising the possibility that cyclin T1 may play a role in HIV replica-
tion during viral reactivation in latently infected cells (Liou et al.,
2002, 2004, 2006). Whether cyclin L2 plays a role in HIV reactiva-
tion or viral alternative splicing remains to be determined.
In the context of HIV-2 infection, Vpx acts as a bridge between
SAMHD1 and DCAF1, resulting in efficient proteasomal degra-
dation of SAMHD1 (Guo et al., 2013; DeLucia et al., 2013).
Although SAMHD1 is established as a restriction factor for
several retroviruses in nondividing cells, how it is regulated inCell Hosthe absence of viral infection is only now beginning to be eluci-
dated. Given the importance of SAMHD1 in regulating nucleotide
levels, especially in noncycling cells, it must be regulated tightly
to prevent excessive nucleotide levels and vice versa. Here
we propose that cyclin L2 is an important factor that targets
SAMHD1 for degradation through DCAF1 in the absence of Vpx.
Recent evidence indicates that SAMHD1 is regulated during
different phases of the cell cycle (Rossi, 2014; Kretschmer
et al., 2014). SAMHD1 is highly phosphorylated in cycling cells
but remains largely unphosphorylated in quiescent cells where
it is active as a restriction factor (St Gelais et al., 2012, 2014;
Cribier et al., 2013). Our study did not find a change in phosphor-
ylation status for SAMHD1 when cyclin L2 was depleted. Rather,
depletion of cyclin L2 resulted in overall increases in the levels of
SAMHD1 in differentiated THP-1 cells. Because the bulk of
SAMHD1 in differentiated macrophages remain unphosphory-
lated, it is reasonable to suggest that depletion of cyclin L2
increases the portion of SAMHD1 relevant for HIV restriction.
Just like Vpx, cyclin L2 also interacts with both DCAF1-DDB1
and SAMHD1 and, in the process, tags SAMHD1 for proteaso-
mal degradation. Because SAMHD1 levels change with different
phases of the cell cycle, it is not surprising that, in the absence of
HIV infection, a DCAF1-interacting protein will mark SAMHD1 for
proteasomal degradation as several important players in the cell
cycle undergo the same fate. A recent report shows that prema-
ture activation of the SLX4 complex by Vpr is critical for the G2/M
cell cycle arrest induced by Vpr, a process that also requires thet & Microbe 17, 98–106, January 14, 2015 ª2015 Elsevier Inc. 103
Figure 6. Effect of Cyclin L2 Depletion on HIV-1 Replication Requires Intact SAMHD1
(A) Differentiated THP-1 cells stably expressing control or cyclin L2 shRNAwere infectedwith HIV for 24 hr.Whole-cell DNAwas isolated, and PCRwas performed
to measure the HIV-1 gag gene. Results are expressed as fold change relative to control.
(B) Differentiated THP-1 cells expressing shRNA to the indicated genes were infected with HIV-1Luc for 48 hr, and viral replication was determined by luciferase
luminescence.
(C) Differentiated THP-1 cells expressing the shRNA to the indicated proteins were infected with HIV-1, and WB was performed after 48 hr.
(D) Quantification of HIV-1 Gag p55/actin for the three experiments from (C).
(E) Differentiated THP-1 cells with or without shRNA to cyclin L2 were infected with HIV-1, and cellular lysates were taken at the indicated time points for western
blot. Blots represent one of three or more experiments.
Data indicate means, and error bars indicate ± SEM (nR 3). **p < 0.001, *p < 0.05, p > 0.05 (ANOVA for multiple comparisons and Student’s t test for pairwise
comparisons).DCAF1-DDB1-Cul4a complex. Given that SLX4 is also involved
in the cell cycle and that cyclin L2 interacts with the DCAF1-
DDB1 complex, it will be interesting to find out whether cyclin
L2 has a role in Vpr-mediated cell cycle arrest (Gritenaite et al.,
2014; Laguette et al., 2014).
We observed a several-fold decrease in HIV-1 reverse tran-
scription products in cyclin L2-depleted cells. This was expected
given that cyclin L2 depletion led to increases in SAMHD1 levels.
Although depletion of SAMHD1 inmacrophages led to increased
replication of HIV, likely due to the availability of nucleotides,
knockdown of cyclin L2 led to a marked reduction in HIV-1 repli-
cation. The effect of cyclin L2 could be rescued when SAMHD1
was depleted. This rescue, although significant, was not com-
plete, indicating that factors other than cyclin L2 are involved
in determining SAMHD1 abundance, and remain to be deter-
mined. Our finding that knockdown of cyclin L2 was less effec-
tive in attenuating HIV-2 replication compared with HIV-1 also
supports our hypothesis that cyclin L2 controls SAMHD1 levels.
The presence of Vpx in HIV-2 most likely reduces the levels of
SAMHD1 and, therefore, blunts the effects of cyclin L2 depletion.
To date, the factors that allowHIV-1 to replicate inmacrophages,
despite the abundance of SAMHD1 in this cell type, have not
been determined. Here we propose that cyclin L2 is an important
factor in macrophages that controls the levels of SAMHD1 to
promote viral replication. Further work will be needed to delin-
eate other players in this interaction and explore cyclin L2 and
its interacting partners as potential therapeutic targets for HIV
in nondividing cells.EXPERIMENTAL PROCEDURES
Cell Lines
For the preparation of macrophages, human monocytes were prepared from
HIV-negative donors by density gradient centrifugation (400 3 g for 30 min)104 Cell Host & Microbe 17, 98–106, January 14, 2015 ª2015 Elseviethrough a Ficoll-Hypaque gradient (GE Healthcare). Monocyte differentiation
was performed for 7 days using 50 ng/ml of recombinant macrophage col-
ony-stimulating factor. THP-1, Jurkat, CEM, and U937 cells were maintained
in RPMI medium supplemented with glucose, glutamine, penicillin/strepto-
mycin, and pyruvate. Where required, THP-1 cells were differentiated for 24–
48 hr in 50 ng/ml of phorbol 12-myristate 13-acetate (PMA). HeLa and 293T
cells were maintained in Dulbecco’s modified Eagle’s medium supplemented
with glutamine, fetal bovine serum, and antibiotics.
Plasmids and shRNA
The Myc-DDK cyclin L2 clone was obtained from OriGene. SAMHD1 was ex-
pressed in a pcDNA3.1 vector with a FLAG tag at its N terminus. DCAF1 was
expressed in a pcDNA3.1 vector with a FLAG-Myc-HA tag at its N terminus.
The HIV-1-Luc reporter virus from a pNL4-3 background, HIV-2Luc, and
HIV-2Dvpx-Luc were from an HIV-2-Rod background with luciferase replacing
the Nef gene in all three molecular clones. All viruses were pseudotyped with
VSV-G for infections. All shRNAs were obtained from the Washington Univer-
sity GenomeCenter. Sequences of the cyclin L2 shRNAs usedwere as follows:
shRNA #1, 50CTTGCAGCTTTATGCTCGGAA30; #2, 50GTGGTCTCAATGTAT
TGACTT30; #3, 50GCGTCTCCTAAGAGGAGGAAA30; #4, 50CCCTACAAAGGC
TCTGAGATT30; and #5, 50GCCTACCAGATTCTGGTGATT30. shRNA #2 was
most effective at knocking down cyclin L2 expression and was used in all
experiments except for the initial screen in Figure 1, where a cocktail of all
five was used, and the experiment shown in Figure 3A, where the designated
shRNAs were used.
Transfections
Cells were transfected using the nucleoporation protocol (Lonza) as described
previously (Chua and Deretic, 2004). Cyclin L2 siRNA knockdown was
achieved using siGENOME SMARTpool (Thermo Fisher Scientific). All effects
of siRNA were compared with a nontargeting siRNA pool (Thermo Fisher
Scientific).
Virus Generation and Infections
HIV-1Luc, HIV2DVpxLuc pseudotyped with the envelope glycoprotein of the
VSV, were obtained as cleared supernatants of HEK293T cells 48 hr after cal-
cium phosphate cotransfection. Viral infections were carried out as described
previously (Olivetta and Federico, 2006). Briefly, infection of THP-1 cells,
monocyte-derived macrophages (MDMs), HEK293T cells, and HeLa cellsr Inc.
was performed by addition of 100, 50, or 10 ng p24 of VSV-G pseudotyped
HIV-1Luc depending on the experiment. HEK293T and HeLa cells were in-
fected with the lower concentrations of virus. A higher concentrations of virus
was used in differentiated THP-1 cells for assays involving western blots of
intracellular Gag. Cells were transduced overnight, washed, and allowed to
go for another 24–48 hr in single-round infection assays. Viral replication
was measured by assessing firefly luciferase activity or HIV-1 Gag in cell ly-
sates. In Figure 1, typical numbers for the normalized reads of luciferase in
control shRNA were as follows: 10,000 units for HIV-1 and HIV-2DVpx and
50,000 units for HIV-2Luc with a background read of <300units. We used lower
concentrations of virus in Figure 1 to increase the chances of observing a bio-
logical effect from the various gene knockdowns.
shRNA virus-like particles were obtained after cotransfection of HEK293T
cells with the pLKO.puro vector containing the shRNA sequence the Gag-
pol obtained from HIV-1, and VSV-G at a ratio of 10:5:1. Cleared supernatant
was used for the transduction of THP-1 cells. Stable cells lines were obtained
with puromycin selection. For knockdown of cyclin L2, freshly isolated periph-
eral blood mononuclear cells were transduced for 24 hr with shRNA virus-like
particles prior to differentiation to macrophages.
Antibodies and Chemicals
Cyclin L2 rabbit polyclonal antibodies were obtained from Novus Biologicals
and ProSci. SAMHD1 mouse polyclonal, rabbit Cul4a, and DDB1 antibodies
were fromAbcam. Goat polyclonal Actin, goat polyclonal cyclin L2, andmouse
monoclonal DCAF1 antibodies were obtained from Santa Cruz Biotechnology.
Rabbit DCAF1 antibody was from Proteintech. Myc and FLAG antibodies were
obtained from Clontech and Sigma, respectively. MG132 was from Sigma.
Mousemonoclonal Gag antibody was obtained through the NIH AIDS Reagent
Program. MTT assay reagents were obtained from Sigma, and the assays
were performed according to the manufacturer’s instructions. Briefly, differen-
tiated THP-1 cells in 12-well plates were infected with HIV-1 for 48 hr, andMTT
assay reagent was added. Cells were incubated for 4 hr and lysed in isopropa-
nol, and then the optical density was measured.
Western Blots and Immunoprecipitations
Cells were washed in PBS and lysed with buffer containing 0.2% NP40 and
protease inhibitor cocktail (Roche). Fifty micrograms of protein were loaded
and separated on a 12.5%SDS-polyacrylamide gel and transferred to nitrocel-
lulose. The membrane was probed overnight at 4C in 5% milk in PBS/Tween
20 (0.05%). After washing with PBS/Tween, the blot was probed with appro-
priate horseradish peroxidase-conjugated secondary antibody for 1 hr at
room temperature and stained with Femto Supersignal. Actin was used as a
loading control. Where indicated, western blots were quantified with ImageJ
software. For immunoprecipitations, transfected HEK293T cells or differenti-
ated THP-1 cells were lysed with buffer containing 0.2% Nonidet P-40 with
protease and phosphatase inhibitors for 1 hr, followed by centrifugation to re-
move cell debris. For cyclin L2/DCAF1 interaction in HEK293T cells, we added
Bafilomycin A1 (Sigma) to stabilize the levels of DCAF1. Coimmunoprecipita-
tions involving overexpression of cyclin L2 and SAMHD1 required expression
of more SAMHD1 to account for its degradation by cyclin L2. Supernatants
were incubated overnight with the immunoprecipitating antibody at 4C. The
immune complexes were captured with protein G–agarose beads (EMD Bio-
sciences) for 1-2 hr or overnight at 4C. Immunoprecipitates were washed
three times with PBS in 0.1% NP40, eluted with SDS-PAGE sample buffer
for 5 min at 100C, and subjected to immunoblot analysis with the appropriate
antibodies. Phos-Tag immunoblots were performed according to the manu-
facturer’s instructions (Wako Pure Chemicals Industries). Phos-Tag gel is
able to separate proteins into phosphorylated (higher molecular weight) and
unphosphorylated portions without the need for phospho antibodies.
Immunofluorescence
Cells on coverslips were fixed for 10 min with 1% paraformaldehyde, washed
twice with PBS, and permeabilized with 0.1% Triton X-100. Blocking with 1%
BSA in PBST was done for 30 min at room temperature. Primary antibodies
were incubated overnight, after which cells were washed, and secondary anti-
body staining with appropriate Alexa fluorescent antibodies (Molecular
Probes) was done for 30 min. Secondary antibody controls were routinely per-
formed and showed no staining pattern without primary antibodies. ImagesCell Hoswere taken and processed on Nikon Epifluorescense microscope. Single cells
were imaged to show vesicular colocalization more clearly.
Quantification of HIV-1 Total DNA
Differentiated THP-1 cells were infected with HIV-1 for 24 hr. DNase I treat-
ment of virus was done for 1 hr prior to infection. Total DNA was isolated using
a kit fromQIAGEN. Quantitative PCRwas performed using gag primers. Quan-
titation of DNA present was done using a standard curve and subtraction of
values obtained from noninfected cells and normalized to control. Actin was
used as an internal control.
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